These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26421998)

  • 1. Site-Directed Mutagenesis of Surface-Exposed Lysine Residues Leads to Improved Transduction by AAV2, But Not AAV8, Vectors in Murine Hepatocytes In Vivo.
    Li B; Ma W; Ling C; Van Vliet K; Huang LY; Agbandje-McKenna M; Srivastava A; Aslanidi GV
    Hum Gene Ther Methods; 2015 Dec; 26(6):211-20. PubMed ID: 26421998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
    Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
    Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?
    Aslanidi GV; Rivers AE; Ortiz L; Song L; Ling C; Govindasamy L; Van Vliet K; Tan M; Agbandje-McKenna M; Srivastava A
    PLoS One; 2013; 8(3):e59142. PubMed ID: 23527116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo.
    Gabriel N; Hareendran S; Sen D; Gadkari RA; Sudha G; Selot R; Hussain M; Dhaksnamoorthy R; Samuel R; Srinivasan N; Srivastava A; Jayandharan GR
    Hum Gene Ther Methods; 2013 Apr; 24(2):80-93. PubMed ID: 23379478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors.
    Chen M; Maeng K; Nawab A; Francois RA; Bray JK; Reinhard MK; Boye SL; Hauswirth WW; Kaye FJ; Aslanidi G; Srivastava A; Zajac-Kaye M
    Hum Gene Ther Methods; 2017 Feb; 28(1):49-59. PubMed ID: 28125909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
    Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
    Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
    Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo.
    Jayandharan GR; Zhong L; Li B; Kachniarz B; Srivastava A
    Gene Ther; 2008 Sep; 15(18):1287-93. PubMed ID: 18496572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.
    Zhong L; Li B; Mah CS; Govindasamy L; Agbandje-McKenna M; Cooper M; Herzog RW; Zolotukhin I; Warrington KH; Weigel-Van Aken KA; Hobbs JA; Zolotukhin S; Muzyczka N; Srivastava A
    Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7827-32. PubMed ID: 18511559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency.
    Shen X; Storm T; Kay MA
    Mol Ther; 2007 Nov; 15(11):1955-62. PubMed ID: 17726459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
    Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
    Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site.
    Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M
    J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8.
    Natkunarajah M; Trittibach P; McIntosh J; Duran Y; Barker SE; Smith AJ; Nathwani AC; Ali RR
    Gene Ther; 2008 Mar; 15(6):463-7. PubMed ID: 18004402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy.
    Li M; Jayandharan GR; Li B; Ling C; Ma W; Srivastava A; Zhong L
    Hum Gene Ther; 2010 Nov; 21(11):1527-43. PubMed ID: 20507237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single tyrosine mutation in AAV8 vector capsid enhances gene lung delivery and does not alter lung morphofunction in mice.
    Martini SV; da Silva AL; Ferreira D; Gomes K; Ornellas FM; Lopes-Pacheco M; Zin E; Petrs-Silva H; Rocco PR; Morales MM
    Cell Physiol Biochem; 2014; 34(3):681-90. PubMed ID: 25171090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells.
    Sayroo R; Nolasco D; Yin Z; Colon-Cortes Y; Pandya M; Ling C; Aslanidi G
    Gene Ther; 2016 Jan; 23(1):18-25. PubMed ID: 26270885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.
    Michelfelder S; Varadi K; Raupp C; Hunger A; Körbelin J; Pahrmann C; Schrepfer S; Müller OJ; Kleinschmidt JA; Trepel M
    PLoS One; 2011; 6(8):e23101. PubMed ID: 21850255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid.
    Vercauteren K; Hoffman BE; Zolotukhin I; Keeler GD; Xiao JW; Basner-Tschakarjan E; High KA; Ertl HC; Rice CM; Srivastava A; de Jong YP; Herzog RW
    Mol Ther; 2016 Jun; 24(6):1042-1049. PubMed ID: 27019999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.
    Markusic DM; Herzog RW; Aslanidi GV; Hoffman BE; Li B; Li M; Jayandharan GR; Ling C; Zolotukhin I; Ma W; Zolotukhin S; Srivastava A; Zhong L
    Mol Ther; 2010 Dec; 18(12):2048-56. PubMed ID: 20736929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.